Minneapolis, MN, United States of America

Roger J Watson


Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 1987-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Roger J Watson

Introduction

Roger J Watson is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of virology, particularly in the development of methods for producing herpes simplex viral proteins. With a total of 3 patents to his name, Watson's work has implications for vaccine development against herpes simplex virus infections.

Latest Patents

Watson's latest patents focus on the production of herpes simplex viral proteins. One of his patents describes methods and compositions for the cloning and expression of the Herpes Simplex Virus (HSV) glycoprotein (gD) gene in single-cell host organisms. This innovation includes methods for culturing these organisms to produce HSV-gene products. The HSV gD-related polypeptides produced through these recombinant DNA techniques may be formulated as immunogens in vaccines to protect against HSV-1 and HSV-2 infections. Another patent similarly outlines methods for cloning and expressing the HSV glycoprotein (gD) gene, emphasizing its potential use in vaccine formulations.

Career Highlights

Throughout his career, Watson has worked with prominent organizations, including American Cyanamid Company and Molecular Genetics Research and Development Limited Partnership. His experience in these companies has contributed to his expertise in genetic research and development.

Collaborations

Watson has collaborated with notable individuals in his field, including Lynn W Enquist and Henry J George. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Roger J Watson's contributions to the field of virology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development against herpes simplex virus infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…